Giovanni Caforio Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 5 days, 8 hours ago

Giovanni Caforio has an estimated net worth of at least $52.5 million*, as of July 16, 2025. They own 432,266 shares of BMY stock. They have sold 445,000 shares of BMY stock since 2021, for an estimated $32.2 million.

Giovanni Caforio $BMY SEC Form 4 Insider Trading

Giovanni Caforio has filed a total of 8 insider trades in $BMY since 2021. Their most recent trade was a sale of 240,000 shares, made on Feb 06, 2023. Their largest trade was a sale of 240,000 shares, made on Feb 06, 2023. We estimate that they now own 432,266 shares of $BMY, worth an estimated $20.3 million.

Insider Trading at $BMY

There have been a total of 43 insider trades reported at $BMY since 2021, with 23,474 shares purchased and 1.3 million shares sold. The most active insider traders in $BMY stock have been Giovanni Caforio, Rupert Vessey, and Ann Powell. The most recent trade was a sale of 97 shares reported by Benjamin Hickey (President, RayzeBio Org.), made on May 09, 2025.

History of Insider Stock Trades by Giovanni Caforio

Company Ticker	Purchase / Sale	Shares	Date	Disclosed (EST)
BMY	Sale	240,000	Feb 06, 2023	Feb. 8, 2023, 9:09 p.m.
BMY	Sale	25,000	Sep 20, 2022	Sept. 22, 2022, 5:12 p.m.
BMY	Sale	50,000	Sep 15, 2022	Sept. 16, 2022, 5:12 p.m.
BMY	Sale	30,000	Jun 13, 2022	June 14, 2022, 5:58 p.m.
BMY	Sale	25,000	Mar 21, 2022	March 23, 2022, 7:43 p.m.
BMY	Sale	30,000	Feb 24, 2022	Feb. 27, 2022, 8 p.m.
BMY	Sale	25,000	Sep 20, 2021	Sept. 21, 2021, 8 p.m.
BMY	Sale	20,000	Aug 02, 2021	Aug. 3, 2021, 8 p.m.

$BMY Executives and Stock Owners with Insider Trades

Giovanni Caforio, Board Chair and CEO
Rupert Vessey, EVP, Research & Early Dev.
Ann Powell, EVP, Chief Human Resources
Autenried Paul Von, EVP, Chief Information Officer
David V Elkins, EVP, Chief Financial Officer
Christopher S. Boerner, Chief Executive Officer
Samit Hirawat, EVP,Chief Med.Offr.,Drug Dev.
Sandra Leung, EVP, General Counsel
Adam Dubow, SVP,ChiefCompliance&EthicsOff.
Benjamin Hickey, President, RayzeBio Org.
Christopher S. Boerner, EVP, Chief Commercial Officer
Giovanni Caforio, Chairman and CEO
Karen Murphy Santiago, SVP & Controller
Phil M Holzer, SVP and Controller
Rupert Vessey, EVP & President, Research
Robert M Plenge, EVP, Chief Research Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.